|MultiCorp International is a publicly traded company that trades on the OTC market under the symbol MCIC.
Our company is incorporated in the state of Delaware.
CEO - David Gustafson
President - Ben Friedman
Medical Advisory Panel - TBD
Financial filings are available at OTC Markets.
118 N. 1600W
Mapleton, UT, 84664
William Aul, ESQ
7676 Hazard Ave.
San Diego, CA, 92108
For companies wishing to assist or partner in the clinical trials of our patent, please email us at
Our Migraine drug patent
|A division of Multicorp International, Inc.
|Understanding the market for migraine medicine
The Migraine Drug Market Will Increase from $3.3 Billion in 2011 to $5.8 Billion in 2021 in the United States, France, Germany,
Italy, Spain, the United Kingdom and Japan
The Pharma Industry Thinks It Finally Has a Fix for Migraines